nodes	percent_of_prediction	percent_of_DWPC	metapath
Sirolimus—SLCO1B1—Methotrexate—psoriatic arthritis	0.0739	0.115	CbGbCtD
Sirolimus—ABCB1—Methylprednisolone—psoriatic arthritis	0.0697	0.109	CbGbCtD
Sirolimus—CYP3A7—Dexamethasone—psoriatic arthritis	0.054	0.0843	CbGbCtD
Sirolimus—CYP3A7-CYP3A51P—Dexamethasone—psoriatic arthritis	0.054	0.0843	CbGbCtD
Sirolimus—ABCB1—Betamethasone—psoriatic arthritis	0.0453	0.0708	CbGbCtD
Sirolimus—ABCB1—Prednisolone—psoriatic arthritis	0.0447	0.0698	CbGbCtD
Sirolimus—ABCB1—Prednisone—psoriatic arthritis	0.0422	0.0659	CbGbCtD
Sirolimus—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0417	0.0652	CbGbCtD
Sirolimus—CYP3A5—Dexamethasone—psoriatic arthritis	0.0405	0.0633	CbGbCtD
Sirolimus—CYP3A4—Triamcinolone—psoriatic arthritis	0.0316	0.0494	CbGbCtD
Sirolimus—CYP3A4—Betamethasone—psoriatic arthritis	0.0271	0.0424	CbGbCtD
Sirolimus—CYP3A4—Prednisolone—psoriatic arthritis	0.0268	0.0418	CbGbCtD
Sirolimus—ABCB1—Dexamethasone—psoriatic arthritis	0.0263	0.0412	CbGbCtD
Sirolimus—CYP3A4—Prednisone—psoriatic arthritis	0.0253	0.0395	CbGbCtD
Sirolimus—ABCB1—Methotrexate—psoriatic arthritis	0.0212	0.0331	CbGbCtD
Sirolimus—CYP3A4—Dexamethasone—psoriatic arthritis	0.0158	0.0247	CbGbCtD
Sirolimus—Anxiety—Methylprednisolone—psoriatic arthritis	0.000267	0.000742	CcSEcCtD
Sirolimus—Infestation NOS—Methotrexate—psoriatic arthritis	0.000267	0.000741	CcSEcCtD
Sirolimus—Infestation—Methotrexate—psoriatic arthritis	0.000267	0.000741	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.000266	0.00074	CcSEcCtD
Sirolimus—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000266	0.000738	CcSEcCtD
Sirolimus—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000266	0.000738	CcSEcCtD
Sirolimus—Discomfort—Triamcinolone—psoriatic arthritis	0.000266	0.000738	CcSEcCtD
Sirolimus—Discomfort—Methylprednisolone—psoriatic arthritis	0.000265	0.000736	CcSEcCtD
Sirolimus—Angioedema—Betamethasone—psoriatic arthritis	0.000262	0.000727	CcSEcCtD
Sirolimus—Angioedema—Dexamethasone—psoriatic arthritis	0.000262	0.000727	CcSEcCtD
Sirolimus—Stomatitis—Methotrexate—psoriatic arthritis	0.00026	0.000722	CcSEcCtD
Sirolimus—Angiopathy—Prednisone—psoriatic arthritis	0.00026	0.000722	CcSEcCtD
Sirolimus—Conjunctivitis—Methotrexate—psoriatic arthritis	0.000259	0.00072	CcSEcCtD
Sirolimus—Confusional state—Methylprednisolone—psoriatic arthritis	0.000259	0.00072	CcSEcCtD
Sirolimus—Immune system disorder—Prednisone—psoriatic arthritis	0.000259	0.000719	CcSEcCtD
Sirolimus—Malaise—Betamethasone—psoriatic arthritis	0.000258	0.000718	CcSEcCtD
Sirolimus—Malaise—Dexamethasone—psoriatic arthritis	0.000258	0.000718	CcSEcCtD
Sirolimus—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000258	0.000716	CcSEcCtD
Sirolimus—Oedema—Triamcinolone—psoriatic arthritis	0.000258	0.000716	CcSEcCtD
Sirolimus—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000257	0.000714	CcSEcCtD
Sirolimus—Syncope—Dexamethasone—psoriatic arthritis	0.000257	0.000714	CcSEcCtD
Sirolimus—Syncope—Betamethasone—psoriatic arthritis	0.000257	0.000714	CcSEcCtD
Sirolimus—Infection—Triamcinolone—psoriatic arthritis	0.000256	0.000711	CcSEcCtD
Sirolimus—Sweating—Methotrexate—psoriatic arthritis	0.000256	0.000711	CcSEcCtD
Sirolimus—Infection—Methylprednisolone—psoriatic arthritis	0.000255	0.00071	CcSEcCtD
Sirolimus—Haematuria—Methotrexate—psoriatic arthritis	0.000254	0.000707	CcSEcCtD
Sirolimus—Shock—Triamcinolone—psoriatic arthritis	0.000254	0.000704	CcSEcCtD
Sirolimus—Insomnia—Prednisolone—psoriatic arthritis	0.000253	0.000704	CcSEcCtD
Sirolimus—Shock—Methylprednisolone—psoriatic arthritis	0.000253	0.000703	CcSEcCtD
Sirolimus—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.000252	0.000701	CcSEcCtD
Sirolimus—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000252	0.0007	CcSEcCtD
Sirolimus—Loss of consciousness—Betamethasone—psoriatic arthritis	0.000252	0.000699	CcSEcCtD
Sirolimus—Loss of consciousness—Dexamethasone—psoriatic arthritis	0.000252	0.000699	CcSEcCtD
Sirolimus—Epistaxis—Methotrexate—psoriatic arthritis	0.000252	0.000699	CcSEcCtD
Sirolimus—Paraesthesia—Prednisolone—psoriatic arthritis	0.000252	0.000699	CcSEcCtD
Sirolimus—Tachycardia—Triamcinolone—psoriatic arthritis	0.000252	0.000699	CcSEcCtD
Sirolimus—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000251	0.000697	CcSEcCtD
Sirolimus—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00025	0.000694	CcSEcCtD
Sirolimus—Malnutrition—Prednisone—psoriatic arthritis	0.00025	0.000693	CcSEcCtD
Sirolimus—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.000249	0.000692	CcSEcCtD
Sirolimus—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.000249	0.00069	CcSEcCtD
Sirolimus—Hypertension—Dexamethasone—psoriatic arthritis	0.000247	0.000687	CcSEcCtD
Sirolimus—Hypertension—Betamethasone—psoriatic arthritis	0.000247	0.000687	CcSEcCtD
Sirolimus—Myalgia—Dexamethasone—psoriatic arthritis	0.000244	0.000678	CcSEcCtD
Sirolimus—Myalgia—Betamethasone—psoriatic arthritis	0.000244	0.000678	CcSEcCtD
Sirolimus—Anxiety—Dexamethasone—psoriatic arthritis	0.000243	0.000675	CcSEcCtD
Sirolimus—Anxiety—Betamethasone—psoriatic arthritis	0.000243	0.000675	CcSEcCtD
Sirolimus—Discomfort—Betamethasone—psoriatic arthritis	0.000241	0.000669	CcSEcCtD
Sirolimus—Discomfort—Dexamethasone—psoriatic arthritis	0.000241	0.000669	CcSEcCtD
Sirolimus—Haemoglobin—Methotrexate—psoriatic arthritis	0.000241	0.000669	CcSEcCtD
Sirolimus—Hypotension—Methylprednisolone—psoriatic arthritis	0.00024	0.000667	CcSEcCtD
Sirolimus—Pain—Prednisolone—psoriatic arthritis	0.00024	0.000666	CcSEcCtD
Sirolimus—Haemorrhage—Methotrexate—psoriatic arthritis	0.00024	0.000665	CcSEcCtD
Sirolimus—Pharyngitis—Methotrexate—psoriatic arthritis	0.000238	0.00066	CcSEcCtD
Sirolimus—Urinary tract disorder—Methotrexate—psoriatic arthritis	0.000237	0.000657	CcSEcCtD
Sirolimus—Urethral disorder—Methotrexate—psoriatic arthritis	0.000235	0.000652	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000235	0.000652	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000234	0.000651	CcSEcCtD
Sirolimus—Oedema—Betamethasone—psoriatic arthritis	0.000234	0.00065	CcSEcCtD
Sirolimus—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.000234	0.00065	CcSEcCtD
Sirolimus—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.000234	0.00065	CcSEcCtD
Sirolimus—Oedema—Dexamethasone—psoriatic arthritis	0.000234	0.00065	CcSEcCtD
Sirolimus—Insomnia—Triamcinolone—psoriatic arthritis	0.000233	0.000647	CcSEcCtD
Sirolimus—Insomnia—Methylprednisolone—psoriatic arthritis	0.000233	0.000646	CcSEcCtD
Sirolimus—Infection—Betamethasone—psoriatic arthritis	0.000232	0.000645	CcSEcCtD
Sirolimus—Infection—Dexamethasone—psoriatic arthritis	0.000232	0.000645	CcSEcCtD
Sirolimus—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000232	0.000643	CcSEcCtD
Sirolimus—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000231	0.000643	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000231	0.000641	CcSEcCtD
Sirolimus—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000231	0.000641	CcSEcCtD
Sirolimus—Visual impairment—Methotrexate—psoriatic arthritis	0.000231	0.000641	CcSEcCtD
Sirolimus—Anaemia—Prednisone—psoriatic arthritis	0.000231	0.000641	CcSEcCtD
Sirolimus—Shock—Betamethasone—psoriatic arthritis	0.00023	0.000639	CcSEcCtD
Sirolimus—Shock—Dexamethasone—psoriatic arthritis	0.00023	0.000639	CcSEcCtD
Sirolimus—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00023	0.000638	CcSEcCtD
Sirolimus—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000229	0.000637	CcSEcCtD
Sirolimus—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000229	0.000637	CcSEcCtD
Sirolimus—Agitation—Prednisone—psoriatic arthritis	0.000229	0.000637	CcSEcCtD
Sirolimus—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.000229	0.000636	CcSEcCtD
Sirolimus—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.000229	0.000636	CcSEcCtD
Sirolimus—Tachycardia—Betamethasone—psoriatic arthritis	0.000228	0.000634	CcSEcCtD
Sirolimus—Tachycardia—Dexamethasone—psoriatic arthritis	0.000228	0.000634	CcSEcCtD
Sirolimus—Angioedema—Prednisone—psoriatic arthritis	0.000228	0.000633	CcSEcCtD
Sirolimus—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000227	0.00063	CcSEcCtD
Sirolimus—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000226	0.000629	CcSEcCtD
Sirolimus—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000226	0.000628	CcSEcCtD
Sirolimus—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000226	0.000628	CcSEcCtD
Sirolimus—Malaise—Prednisone—psoriatic arthritis	0.000225	0.000625	CcSEcCtD
Sirolimus—Syncope—Prednisone—psoriatic arthritis	0.000224	0.000622	CcSEcCtD
Sirolimus—Tinnitus—Methotrexate—psoriatic arthritis	0.000223	0.00062	CcSEcCtD
Sirolimus—Anorexia—Dexamethasone—psoriatic arthritis	0.000223	0.000619	CcSEcCtD
Sirolimus—Anorexia—Betamethasone—psoriatic arthritis	0.000223	0.000619	CcSEcCtD
Sirolimus—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000222	0.000618	CcSEcCtD
Sirolimus—Pain—Triamcinolone—psoriatic arthritis	0.00022	0.000612	CcSEcCtD
Sirolimus—Loss of consciousness—Prednisone—psoriatic arthritis	0.000219	0.000609	CcSEcCtD
Sirolimus—Hypotension—Betamethasone—psoriatic arthritis	0.000219	0.000607	CcSEcCtD
Sirolimus—Hypotension—Dexamethasone—psoriatic arthritis	0.000219	0.000607	CcSEcCtD
Sirolimus—Angiopathy—Methotrexate—psoriatic arthritis	0.000217	0.000604	CcSEcCtD
Sirolimus—Immune system disorder—Methotrexate—psoriatic arthritis	0.000216	0.000601	CcSEcCtD
Sirolimus—Mediastinal disorder—Methotrexate—psoriatic arthritis	0.000216	0.0006	CcSEcCtD
Sirolimus—Hypertension—Prednisone—psoriatic arthritis	0.000215	0.000598	CcSEcCtD
Sirolimus—Chills—Methotrexate—psoriatic arthritis	0.000215	0.000597	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000213	0.000592	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000213	0.000592	CcSEcCtD
Sirolimus—Arthralgia—Prednisone—psoriatic arthritis	0.000212	0.00059	CcSEcCtD
Sirolimus—Myalgia—Prednisone—psoriatic arthritis	0.000212	0.00059	CcSEcCtD
Sirolimus—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000212	0.00059	CcSEcCtD
Sirolimus—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000212	0.000589	CcSEcCtD
Sirolimus—Anxiety—Prednisone—psoriatic arthritis	0.000212	0.000588	CcSEcCtD
Sirolimus—Insomnia—Betamethasone—psoriatic arthritis	0.000212	0.000587	CcSEcCtD
Sirolimus—Insomnia—Dexamethasone—psoriatic arthritis	0.000212	0.000587	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.000211	0.000586	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00021	0.000584	CcSEcCtD
Sirolimus—Paraesthesia—Betamethasone—psoriatic arthritis	0.00021	0.000583	CcSEcCtD
Sirolimus—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00021	0.000583	CcSEcCtD
Sirolimus—Discomfort—Prednisone—psoriatic arthritis	0.00021	0.000583	CcSEcCtD
Sirolimus—Malnutrition—Methotrexate—psoriatic arthritis	0.000209	0.000579	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000206	0.000574	CcSEcCtD
Sirolimus—Dyspepsia—Betamethasone—psoriatic arthritis	0.000206	0.000572	CcSEcCtD
Sirolimus—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000206	0.000572	CcSEcCtD
Sirolimus—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000204	0.000566	CcSEcCtD
Sirolimus—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000204	0.000566	CcSEcCtD
Sirolimus—Oedema—Prednisone—psoriatic arthritis	0.000204	0.000566	CcSEcCtD
Sirolimus—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000203	0.000565	CcSEcCtD
Sirolimus—Decreased appetite—Betamethasone—psoriatic arthritis	0.000203	0.000565	CcSEcCtD
Sirolimus—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000203	0.000565	CcSEcCtD
Sirolimus—Infection—Prednisone—psoriatic arthritis	0.000202	0.000562	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000202	0.000561	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000202	0.000561	CcSEcCtD
Sirolimus—Back pain—Methotrexate—psoriatic arthritis	0.000202	0.00056	CcSEcCtD
Sirolimus—Shock—Prednisone—psoriatic arthritis	0.0002	0.000557	CcSEcCtD
Sirolimus—Pain—Betamethasone—psoriatic arthritis	0.0002	0.000555	CcSEcCtD
Sirolimus—Pain—Dexamethasone—psoriatic arthritis	0.0002	0.000555	CcSEcCtD
Sirolimus—Nervous system disorder—Prednisone—psoriatic arthritis	0.0002	0.000555	CcSEcCtD
Sirolimus—Tachycardia—Prednisone—psoriatic arthritis	0.000199	0.000552	CcSEcCtD
Sirolimus—Skin disorder—Prednisone—psoriatic arthritis	0.000198	0.000549	CcSEcCtD
Sirolimus—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000197	0.000547	CcSEcCtD
Sirolimus—Anorexia—Prednisone—psoriatic arthritis	0.000194	0.000539	CcSEcCtD
Sirolimus—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000194	0.000537	CcSEcCtD
Sirolimus—Anaemia—Methotrexate—psoriatic arthritis	0.000193	0.000535	CcSEcCtD
Sirolimus—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000193	0.000535	CcSEcCtD
Sirolimus—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000193	0.000535	CcSEcCtD
Sirolimus—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000191	0.000531	CcSEcCtD
Sirolimus—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000191	0.000531	CcSEcCtD
Sirolimus—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00019	0.000527	CcSEcCtD
Sirolimus—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000189	0.000526	CcSEcCtD
Sirolimus—Malaise—Methotrexate—psoriatic arthritis	0.000188	0.000522	CcSEcCtD
Sirolimus—Leukopenia—Methotrexate—psoriatic arthritis	0.000187	0.000518	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000186	0.000515	CcSEcCtD
Sirolimus—Dizziness—Prednisolone—psoriatic arthritis	0.000185	0.000515	CcSEcCtD
Sirolimus—Asthenia—Triamcinolone—psoriatic arthritis	0.000185	0.000514	CcSEcCtD
Sirolimus—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000185	0.000513	CcSEcCtD
Sirolimus—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000185	0.000513	CcSEcCtD
Sirolimus—Abdominal pain—Betamethasone—psoriatic arthritis	0.000185	0.000513	CcSEcCtD
Sirolimus—Body temperature increased—Betamethasone—psoriatic arthritis	0.000185	0.000513	CcSEcCtD
Sirolimus—Asthenia—Methylprednisolone—psoriatic arthritis	0.000185	0.000512	CcSEcCtD
Sirolimus—Insomnia—Prednisone—psoriatic arthritis	0.000184	0.000512	CcSEcCtD
Sirolimus—Paraesthesia—Prednisone—psoriatic arthritis	0.000183	0.000508	CcSEcCtD
Sirolimus—Pruritus—Triamcinolone—psoriatic arthritis	0.000182	0.000506	CcSEcCtD
Sirolimus—Cough—Methotrexate—psoriatic arthritis	0.000182	0.000505	CcSEcCtD
Sirolimus—Pruritus—Methylprednisolone—psoriatic arthritis	0.000182	0.000505	CcSEcCtD
Sirolimus—Dyspepsia—Prednisone—psoriatic arthritis	0.000179	0.000498	CcSEcCtD
Sirolimus—Arthralgia—Methotrexate—psoriatic arthritis	0.000178	0.000493	CcSEcCtD
Sirolimus—Chest pain—Methotrexate—psoriatic arthritis	0.000178	0.000493	CcSEcCtD
Sirolimus—Myalgia—Methotrexate—psoriatic arthritis	0.000178	0.000493	CcSEcCtD
Sirolimus—Decreased appetite—Prednisone—psoriatic arthritis	0.000177	0.000492	CcSEcCtD
Sirolimus—Rash—Prednisolone—psoriatic arthritis	0.000177	0.000491	CcSEcCtD
Sirolimus—Dermatitis—Prednisolone—psoriatic arthritis	0.000177	0.00049	CcSEcCtD
Sirolimus—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000176	0.00049	CcSEcCtD
Sirolimus—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000176	0.000489	CcSEcCtD
Sirolimus—Headache—Prednisolone—psoriatic arthritis	0.000176	0.000488	CcSEcCtD
Sirolimus—Discomfort—Methotrexate—psoriatic arthritis	0.000175	0.000487	CcSEcCtD
Sirolimus—Constipation—Prednisone—psoriatic arthritis	0.000174	0.000484	CcSEcCtD
Sirolimus—Confusional state—Methotrexate—psoriatic arthritis	0.000172	0.000477	CcSEcCtD
Sirolimus—Dizziness—Triamcinolone—psoriatic arthritis	0.00017	0.000473	CcSEcCtD
Sirolimus—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.00017	0.000473	CcSEcCtD
Sirolimus—Dizziness—Methylprednisolone—psoriatic arthritis	0.00017	0.000472	CcSEcCtD
Sirolimus—Infection—Methotrexate—psoriatic arthritis	0.000169	0.00047	CcSEcCtD
Sirolimus—Feeling abnormal—Prednisone—psoriatic arthritis	0.000168	0.000466	CcSEcCtD
Sirolimus—Asthenia—Dexamethasone—psoriatic arthritis	0.000168	0.000466	CcSEcCtD
Sirolimus—Asthenia—Betamethasone—psoriatic arthritis	0.000168	0.000466	CcSEcCtD
Sirolimus—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000167	0.000464	CcSEcCtD
Sirolimus—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000167	0.000463	CcSEcCtD
Sirolimus—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000167	0.000463	CcSEcCtD
Sirolimus—Nausea—Prednisolone—psoriatic arthritis	0.000166	0.000462	CcSEcCtD
Sirolimus—Pruritus—Betamethasone—psoriatic arthritis	0.000165	0.00046	CcSEcCtD
Sirolimus—Pruritus—Dexamethasone—psoriatic arthritis	0.000165	0.00046	CcSEcCtD
Sirolimus—Skin disorder—Methotrexate—psoriatic arthritis	0.000165	0.000459	CcSEcCtD
Sirolimus—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000165	0.000457	CcSEcCtD
Sirolimus—Vomiting—Triamcinolone—psoriatic arthritis	0.000164	0.000455	CcSEcCtD
Sirolimus—Vomiting—Methylprednisolone—psoriatic arthritis	0.000164	0.000454	CcSEcCtD
Sirolimus—Rash—Triamcinolone—psoriatic arthritis	0.000163	0.000451	CcSEcCtD
Sirolimus—Dermatitis—Triamcinolone—psoriatic arthritis	0.000162	0.000451	CcSEcCtD
Sirolimus—Anorexia—Methotrexate—psoriatic arthritis	0.000162	0.000451	CcSEcCtD
Sirolimus—Rash—Methylprednisolone—psoriatic arthritis	0.000162	0.00045	CcSEcCtD
Sirolimus—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000162	0.00045	CcSEcCtD
Sirolimus—Headache—Triamcinolone—psoriatic arthritis	0.000161	0.000448	CcSEcCtD
Sirolimus—Headache—Methylprednisolone—psoriatic arthritis	0.000161	0.000447	CcSEcCtD
Sirolimus—Body temperature increased—Prednisone—psoriatic arthritis	0.000161	0.000447	CcSEcCtD
Sirolimus—Abdominal pain—Prednisone—psoriatic arthritis	0.000161	0.000447	CcSEcCtD
Sirolimus—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00016	0.000444	CcSEcCtD
Sirolimus—Diarrhoea—Betamethasone—psoriatic arthritis	0.00016	0.000444	CcSEcCtD
Sirolimus—Hypotension—Methotrexate—psoriatic arthritis	0.000159	0.000442	CcSEcCtD
Sirolimus—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000155	0.000431	CcSEcCtD
Sirolimus—Dizziness—Dexamethasone—psoriatic arthritis	0.000155	0.00043	CcSEcCtD
Sirolimus—Dizziness—Betamethasone—psoriatic arthritis	0.000155	0.00043	CcSEcCtD
Sirolimus—Insomnia—Methotrexate—psoriatic arthritis	0.000154	0.000428	CcSEcCtD
Sirolimus—Nausea—Triamcinolone—psoriatic arthritis	0.000153	0.000425	CcSEcCtD
Sirolimus—Paraesthesia—Methotrexate—psoriatic arthritis	0.000153	0.000424	CcSEcCtD
Sirolimus—Nausea—Methylprednisolone—psoriatic arthritis	0.000153	0.000424	CcSEcCtD
Sirolimus—Dyspnoea—Methotrexate—psoriatic arthritis	0.000152	0.000421	CcSEcCtD
Sirolimus—Somnolence—Methotrexate—psoriatic arthritis	0.000151	0.00042	CcSEcCtD
Sirolimus—Hypersensitivity—Prednisone—psoriatic arthritis	0.00015	0.000417	CcSEcCtD
Sirolimus—Dyspepsia—Methotrexate—psoriatic arthritis	0.00015	0.000416	CcSEcCtD
Sirolimus—Vomiting—Dexamethasone—psoriatic arthritis	0.000149	0.000413	CcSEcCtD
Sirolimus—Vomiting—Betamethasone—psoriatic arthritis	0.000149	0.000413	CcSEcCtD
Sirolimus—Decreased appetite—Methotrexate—psoriatic arthritis	0.000148	0.000411	CcSEcCtD
Sirolimus—Rash—Dexamethasone—psoriatic arthritis	0.000147	0.00041	CcSEcCtD
Sirolimus—Rash—Betamethasone—psoriatic arthritis	0.000147	0.00041	CcSEcCtD
Sirolimus—Dermatitis—Dexamethasone—psoriatic arthritis	0.000147	0.000409	CcSEcCtD
Sirolimus—Dermatitis—Betamethasone—psoriatic arthritis	0.000147	0.000409	CcSEcCtD
Sirolimus—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000147	0.000408	CcSEcCtD
Sirolimus—Headache—Dexamethasone—psoriatic arthritis	0.000147	0.000407	CcSEcCtD
Sirolimus—Headache—Betamethasone—psoriatic arthritis	0.000147	0.000407	CcSEcCtD
Sirolimus—Asthenia—Prednisone—psoriatic arthritis	0.000146	0.000406	CcSEcCtD
Sirolimus—Pain—Methotrexate—psoriatic arthritis	0.000146	0.000404	CcSEcCtD
Sirolimus—Pruritus—Prednisone—psoriatic arthritis	0.000144	0.0004	CcSEcCtD
Sirolimus—Feeling abnormal—Methotrexate—psoriatic arthritis	0.00014	0.00039	CcSEcCtD
Sirolimus—Diarrhoea—Prednisone—psoriatic arthritis	0.000139	0.000387	CcSEcCtD
Sirolimus—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000139	0.000387	CcSEcCtD
Sirolimus—Nausea—Betamethasone—psoriatic arthritis	0.000139	0.000386	CcSEcCtD
Sirolimus—Nausea—Dexamethasone—psoriatic arthritis	0.000139	0.000386	CcSEcCtD
Sirolimus—Dizziness—Prednisone—psoriatic arthritis	0.000135	0.000374	CcSEcCtD
Sirolimus—Abdominal pain—Methotrexate—psoriatic arthritis	0.000135	0.000374	CcSEcCtD
Sirolimus—Body temperature increased—Methotrexate—psoriatic arthritis	0.000135	0.000374	CcSEcCtD
Sirolimus—Vomiting—Prednisone—psoriatic arthritis	0.000129	0.00036	CcSEcCtD
Sirolimus—Rash—Prednisone—psoriatic arthritis	0.000128	0.000357	CcSEcCtD
Sirolimus—Dermatitis—Prednisone—psoriatic arthritis	0.000128	0.000356	CcSEcCtD
Sirolimus—Headache—Prednisone—psoriatic arthritis	0.000128	0.000354	CcSEcCtD
Sirolimus—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000125	0.000348	CcSEcCtD
Sirolimus—Asthenia—Methotrexate—psoriatic arthritis	0.000122	0.000339	CcSEcCtD
Sirolimus—Nausea—Prednisone—psoriatic arthritis	0.000121	0.000336	CcSEcCtD
Sirolimus—Pruritus—Methotrexate—psoriatic arthritis	0.00012	0.000334	CcSEcCtD
Sirolimus—Diarrhoea—Methotrexate—psoriatic arthritis	0.000116	0.000323	CcSEcCtD
Sirolimus—Dizziness—Methotrexate—psoriatic arthritis	0.000113	0.000313	CcSEcCtD
Sirolimus—Vomiting—Methotrexate—psoriatic arthritis	0.000108	0.000301	CcSEcCtD
Sirolimus—Rash—Methotrexate—psoriatic arthritis	0.000107	0.000298	CcSEcCtD
Sirolimus—Dermatitis—Methotrexate—psoriatic arthritis	0.000107	0.000298	CcSEcCtD
Sirolimus—Headache—Methotrexate—psoriatic arthritis	0.000107	0.000296	CcSEcCtD
Sirolimus—Nausea—Methotrexate—psoriatic arthritis	0.000101	0.000281	CcSEcCtD
